Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on May 15, 2025

82-Acre Off-Market Texas Tract Available for AI, Crypto and Energy Development
Texas Land Opportunity for Global Investors: 82 acres unzoned Texas land near Dallas for $1.2M. Ideal for global AI, crypto, …

DermaSensor Welcomes Carolyn Walsh as Chief Commercial Officer and Announces Commercial Advisory Board
MIAMI, FL, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- DermaSensor Inc., a health technology company that commercialized the first skin cancer diagnostic tool for primary care physicians, today announced the appointment of Carolyn Walsh as Chief …

Bharti Airtel Partners with TierOne to Automate Application Assurance and Boost NOC Efficiency
MISSISSAUGA, ONTARIO, CANADA, May 15, 2025 /EINPresswire.com/ -- Bharti Airtel has partnered with TierOne to launch an unmatched application assurance initiative aimed at increasing reliability and reducing the operational overhead across its mission- …

Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures
New York, May 15, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: How The Encyclopedia of Natural Remedies by 365 Daily Health unveils ancient biblical remedies drawn from scripture Why chronic health issues like inflammation, fatigue, and …

Openxcell Rolls Out MediMind - An Intelligent AI Healthcare Chatbot Assistant to Revolutionize Medical Care
A leading AI development company, Openxcell, has launched a remarkable AI healthcare solution, MediMind, to revolutionize the healthcare process. LAS VEGAS, NV, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- Artificial intelligence and its solutions …

FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance
San Diego, May 15, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why millions of Americans are turning to GLP-1 semaglutide prescriptions for weight loss without insurance The top pain points consumers face in traditional weight loss and …

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results
MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. …

BioSyent Releases Financial Results for First Quarter 2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2025. Key highlights include: (CAD) Q1 2025 % Change vs. Q1 2024 Trailing …

BioSyent Declares Second Quarter 2025 Dividend
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on …

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic …

Shuttle Pharma Provides Corporate Update
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a …

Combined General Meeting of June 11, 2025
Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a …

Assemblée Générale Mixte du 11 juin 2025
Châtillon, France, le 15 mai 2025 Assemblée Générale Mixte du 11 juin 2025 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market …

Hapbee Technologies Teams Up with Liberty Alliance to Deliver Wearable Sleep and Performance Technology to the Defense Sector; Updates Status of Audited Financial Statements
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF), a leading provider of wearable wellness technology, is proud to announce it has teamed up with Liberty Alliance, a veteran-owned business ( …

Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an …

Globus Medical Announces $500 Million Share Repurchase Program
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s …

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for …